Korn/Ferry CEO Paul Riley and C-Level Compensation and Recruitment

Recruitment and turnover are becoming a problem, he says.
Jan. 1, 1970
Recruitment and turnover are becoming a problem, he says.

About the Author

pharmamanufacturing

pharmamanufacturing

Sign up for our eNewsletters
Get the latest news and updates

Related

Fujifilm Biotechnologies to leverage downstream purification system at UK site
‘Cobots’ drive pharma’s shift toward scalable cell therapies
Webinar: 2026 Life Sciences Industry Trends: Connecting Quality, Manufacturing, and Asset Management
Sponsored
Accelerating Pharma Digital Transformation: Live Webinar with ISPE
Sponsored